WebFeb 22, 2024 · Since December 2024, medac GmbH, a privately held, multi-national pharmaceutical company based in Germany, has been the licensee for CHEMOSAT in Europe. Delcath and medac are working closely together on … WebFeb 22, 2024 · Since December 2024, medac GmbH, a privately held, multi-national pharmaceutical company based in Germany, has been the licensee for CHEMOSAT in …
Positive Preliminary Results from Delcath Systems
WebMay 27, 2024 · CHEMOSAT ®, marketed by medac Pharma, is a minimally invasive delivery system for the administration of high-dose chemotherapy directly to the liver … WebDelcath is now offering Expanded Access to our Melphalan/HDS Therapy: 1. Expanded Access Program – Percutaneous Hepatic Perfusion (PHP) with Melphalan/HDS in Patients with Hepatic-Dominant Metastatic Ocular Melanoma. 2. FOCUS 301A study – A Single-arm, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ... gun shy with sandra bullock
Delcath Systems Reports Third Quarter 2024 Results and Provides ...
WebMay 11, 2024 · NEW YORK, May 11, 2024 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the first quarter ended March 31, 2024. Recent Business Highlights. During and since … WebDec 26, 2024 · Delcath Systems (NASDAQ:DCTH +31.4%) has entered into a definitive licensing agreement for CHEMOSAT® commercialization in Europe with medac … WebSep 3, 2024 · Medac Pharma has appointed Kirk Chester as national account manager for the organisation’s newest hepatic oncology product, Chemosat. Kirk brings with him to … gun shy tv show